Abu Dhabi Stem Cells Center and Yas Clinic first in UAE to receive AABB accreditation for haematopoietic progenitor cell collection
Abu Dhabi Stem Cells Center (ADSCC) and Yas Clinic have been granted a highly regarded global accreditation by AABB (formerly known as the American Association of Blood Banks) for Hematopoietic Progenitor Cell Collection. This achievement marks ADSCC and Yas Clinic as the first to earn this accreditation in the UAE, and the second in the Middle East and North Africa region (MENA), meeting the highest standards of quality and safety in in the procurement, processing, and storage of hematopoietic progenitor cells, which are critical for transplantation and treating various blood disorders and autoimmune diseases.
As a Centre of Excellence in Hematopoietic Stem Cell Transplantation, accredited by the Department of Health Abu Dhabi and an accredited facility by the Foundation of Accreditation for Cellular Therapy (FACT), ADSCC and Yas Clinic's AABB accreditation further reinforces their commitment to excellence in cellular therapy and solidifies their leadership in regenerative medicine. Earning these three accreditations for cellular therapies in only 24 months is a testament to their dedication to the highest standards of quality, safety, and innovation in patient care within their Abu Dhabi Bone Marrow Transplant Program and their fully-fledged CAR-T and Mesenchymal Stem Cells programmes.
Prof Yendry Ventura, Chief Executive Officer of ADSCC and Adjunct Professor at United Arab Emirates University, said: 'Under the visionary leadership of the UAE and in alignment with the national healthcare agenda, ADSCC and Yas Clinic remain dedicated to advancing cellular therapy and medical innovation on a global scale. Achieving AABB accreditation marks a significant milestone in our commitment to excellence in cellular therapies. As the first institution in the UAE to receive this prestigious accreditation, we continue to set new benchmarks in quality and patient safety which is backed by a solid infrastructure, a state-of-the-art apheresis and ECP unit, and unparalleled clinical expertise. This achievement underscores our dedication to pioneering cutting-edge treatments, enhancing healthcare standards, and reinforcing UAE's position as a regional leader in regenerative medicine and biological sciences.'
Dr Maysoon Al Karam, Chief Medical Officer at Yas Clinic operated by ADSCC , said: 'This achievement reflects the efforts and expertise of our entire team of scientists, haematologists, immunologists, nurses and technicians and beyond. Being one of only two AABB-accredited facilities in the MENA region for HPC collection is a significant milestone for our patients and also physicians, and we are proud to contribute to the advancement of cellular therapy in the UAE and beyond. This accreditation positions ADSCC and Yas Clinic as a regional leader in bone marrow transplant and cellular therapy and reinforces our role in providing cutting-edge treatments to patients.'
AABB's accreditation programme is the leader in ensuring the highest level of quality and safety for the blood and biotherapies field. AABB's accreditation programme promotes the highest standards of care for patients, donors, processes and products in all aspects of transfusion medicine, biotherapies and relationship testing.
About Abu Dhabi Stem Cells Center ADSCC:
Abu Dhabi Stem Cells Center (ADSCC) is a renowned healthcare institution in Abu Dhabi, UAE, specialising in advanced stem cell therapy, research, and regenerative medicine. ADSCC is the incubator of the Abu Dhabi Bone Marrow Transplant (AD-BMT © ) program, the first comprehensive programme to provide autologous and allogeneic hematopoietic stem cells transplant (HSCT) for adult and paediatric patients in the UAE since 2020. As a Center of Excellence in Hematopoietic Stem Cell Transplantation accredited by the Department of Health – Abu Dhabi, ADSCC's holistic service model includes advanced research, clinical trials, translational care, and manufacturing capabilities. ADSCC has one of the region's most advanced and sophisticated research labs and a robust multidisciplinary hospital. It is the only center in the UAE to encompass a cell processing laboratory, a state-of-the-art apheresis unit, a stem cell collection unit, a Good Manufacturing Practice (GMP) laboratory, and dedicated multi-specialty outpatient clinics and inpatient wards. As the UAE's first and most experienced stem cell transplant center, ADSCC has received multiple prestigious recognitions and conducted strategic collaborations, solidifying its position as a center of excellence. In 2024, ADSCC received accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) for its cellular therapy processing laboratory, the first in UAE and one of only two in Middle East to receive this global accreditation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
13-05-2025
- Mid East Info
First Response Healthcare launches innovative mobile app, aiming to provide personalised medical care at home in the UAE
The company announced the launch of their 'Drect' app during their annual event, reinforcing its commitment to patient-focused solutions Dubai, UAE: First Response Healthcare (FRH), a leader in at-home healthcare services, has officially launched its eagerly awaited mobile app 'Drect' during its annual internal award show. The event—which followed a theme of technology, diversity, and growth—celebrated the achievements of their team while reinforcing the company's commitment to leveraging technology for accessible, patient-first healthcare solutions. Drect has been expertly designed to streamline healthcare access, allowing patients to effortlessly book and manage medical services at the touch of a button. Users will enjoy 24/7 access to doctors, pediatricians, and dentists with an average arrival time of 30 minutes. GPS technology ensures effortless tracking of medical teams, while a secure storage system allows patients to receive blood test results, prescriptions, and invoices safely within the app. Tourists visiting the region can simply scan a QR code in their hotel room and request a doctor in just two clicks—bringing peace of mind to their travels. An innovative Health Chat and Teleconsult have been seamlessly integrated, supporting the company's vision of making high-quality healthcare more accessible and convenient. Pavan Sharma, Founder and CEO of First Response Healthcare, expressed his excitement about the launch: 'We've built Drect around the needs of our patients, making care more accessible, personalised, and seamless. It's a foundation for even greater innovation as we look at integrating AI, IoT, and real-time health tracking, empowering residents of Dubai to get quality medical care at the tap of a button without leaving home.' 'This app is our answer to a constant question at FRH: how can we deliver even more value to the patients who trust us? By combining convenience with intelligent technology, we're setting the stage for a more connected, proactive, and patient-first approach to primary care,' added Prashi Sharma, Chief Strategy Officer at First Response Healthcare. As a pioneering at-home healthcare provider in Dubai, FRH has consistently set industry benchmarks since its establishment in 2018. With JCI accreditation and DHA licensing, the company guarantees top-tier medical care, serving over 250 premium hotels and private clients. FRH remains a leading licensed provider of Pediatrician at Home and Dentist at Home services, equipped with fully portable medical equipment. With the mobile app and ambitious expansion plans underway, First Response Healthcare continues to reimagine healthcare accessibility in the region, reinforcing its mission to deliver excellence in medical here About First Response Healthcare: First Response Healthcare is a pioneering at-home healthcare provider dedicated to redefining the standard of urgent medical care. Established in 2018, they are the first JCI-Accredited and DHA-Licensed Home Health Care Organisation in Dubai. This accreditation ensures that the quality of each treatment is of the highest standards. With over 6 years of experience and serving 150+ premium hotels and clients, they have a proven track record of delivering exceptional care. As a pioneer in the industry, FRH is the only company licensed for Pediatrician at Home and Dentist at Home services in Dubai, equipped with completely portable equipment.
CairoScene
13-05-2025
- CairoScene
Egypt Prepares First AI-Powered National Platform for Remote Diagnosis
Backed by WHO guidelines, the new platform aims to boost diagnostic speed and accuracy across Egypt's healthcare system. May 13, 2025 Egypt is preparing the pilot launch of its first national artificial intelligence-based platform for remote medical diagnosis, according to Dr. Ahmed El-Sobky, Chairman of the General Authority for Healthcare and Supervisor of the Comprehensive Health Insurance Project. The new platform will rely on the latest treatment protocols issued by the World Health Organization (WHO), with the goal of improving diagnostic accuracy and reducing response times across public health services. The announcement came during a meeting between Dr. El-Sobky and Dr. Nima Saeed Abid, WHO Representative in Egypt, as the two parties discussed strategies to advance the country's healthcare system. Dr. El-Sobky noted that the Authority is already a regional leader in adopting global medical standards, having implemented both the ICD-11 disease classification and ICHI intervention coding systems—becoming the first healthcare body in the MENA region to do so. These systems are expected to significantly improve public health tracking, inform national health policies, and support clinical decision-making at scale. The AI platform is part of a broader digital transformation plan aimed at aligning Egypt's healthcare sector with international best practices. The collaboration between WHO and the General Authority for Healthcare focuses on six key areas, including joint research, the establishment of a WHO-accredited emergency medical team, and the launch of a Collaboration Centre specialising in clinical governance and infection control. These initiatives are designed to enhance care quality and safety across Egypt's healthcare infrastructure.
Mid East Info
13-03-2025
- Mid East Info
Abu Dhabi Stem Cells Center and Yas Clinic first in UAE to receive AABB accreditation for haematopoietic progenitor cell collection
Abu Dhabi Stem Cells Center (ADSCC) and Yas Clinic have been granted a highly regarded global accreditation by AABB (formerly known as the American Association of Blood Banks) for Hematopoietic Progenitor Cell Collection. This achievement marks ADSCC and Yas Clinic as the first to earn this accreditation in the UAE, and the second in the Middle East and North Africa region (MENA), meeting the highest standards of quality and safety in in the procurement, processing, and storage of hematopoietic progenitor cells, which are critical for transplantation and treating various blood disorders and autoimmune diseases. As a Centre of Excellence in Hematopoietic Stem Cell Transplantation, accredited by the Department of Health Abu Dhabi and an accredited facility by the Foundation of Accreditation for Cellular Therapy (FACT), ADSCC and Yas Clinic's AABB accreditation further reinforces their commitment to excellence in cellular therapy and solidifies their leadership in regenerative medicine. Earning these three accreditations for cellular therapies in only 24 months is a testament to their dedication to the highest standards of quality, safety, and innovation in patient care within their Abu Dhabi Bone Marrow Transplant Program and their fully-fledged CAR-T and Mesenchymal Stem Cells programmes. Prof Yendry Ventura, Chief Executive Officer of ADSCC and Adjunct Professor at United Arab Emirates University, said: 'Under the visionary leadership of the UAE and in alignment with the national healthcare agenda, ADSCC and Yas Clinic remain dedicated to advancing cellular therapy and medical innovation on a global scale. Achieving AABB accreditation marks a significant milestone in our commitment to excellence in cellular therapies. As the first institution in the UAE to receive this prestigious accreditation, we continue to set new benchmarks in quality and patient safety which is backed by a solid infrastructure, a state-of-the-art apheresis and ECP unit, and unparalleled clinical expertise. This achievement underscores our dedication to pioneering cutting-edge treatments, enhancing healthcare standards, and reinforcing UAE's position as a regional leader in regenerative medicine and biological sciences.' Dr Maysoon Al Karam, Chief Medical Officer at Yas Clinic operated by ADSCC , said: 'This achievement reflects the efforts and expertise of our entire team of scientists, haematologists, immunologists, nurses and technicians and beyond. Being one of only two AABB-accredited facilities in the MENA region for HPC collection is a significant milestone for our patients and also physicians, and we are proud to contribute to the advancement of cellular therapy in the UAE and beyond. This accreditation positions ADSCC and Yas Clinic as a regional leader in bone marrow transplant and cellular therapy and reinforces our role in providing cutting-edge treatments to patients.' AABB's accreditation programme is the leader in ensuring the highest level of quality and safety for the blood and biotherapies field. AABB's accreditation programme promotes the highest standards of care for patients, donors, processes and products in all aspects of transfusion medicine, biotherapies and relationship testing. About Abu Dhabi Stem Cells Center ADSCC: Abu Dhabi Stem Cells Center (ADSCC) is a renowned healthcare institution in Abu Dhabi, UAE, specialising in advanced stem cell therapy, research, and regenerative medicine. ADSCC is the incubator of the Abu Dhabi Bone Marrow Transplant (AD-BMT © ) program, the first comprehensive programme to provide autologous and allogeneic hematopoietic stem cells transplant (HSCT) for adult and paediatric patients in the UAE since 2020. As a Center of Excellence in Hematopoietic Stem Cell Transplantation accredited by the Department of Health – Abu Dhabi, ADSCC's holistic service model includes advanced research, clinical trials, translational care, and manufacturing capabilities. ADSCC has one of the region's most advanced and sophisticated research labs and a robust multidisciplinary hospital. It is the only center in the UAE to encompass a cell processing laboratory, a state-of-the-art apheresis unit, a stem cell collection unit, a Good Manufacturing Practice (GMP) laboratory, and dedicated multi-specialty outpatient clinics and inpatient wards. As the UAE's first and most experienced stem cell transplant center, ADSCC has received multiple prestigious recognitions and conducted strategic collaborations, solidifying its position as a center of excellence. In 2024, ADSCC received accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) for its cellular therapy processing laboratory, the first in UAE and one of only two in Middle East to receive this global accreditation.
